Kalaris Therapeutics, Inc. (KLRS)
2.27
+0.01
(+0.44%)
USD |
NASDAQ |
Oct 13, 09:43
Kalaris Therapeutics 1 Year Total Returns (Daily) : -49.21% for Oct. 12, 2026
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| October 12, 2026 | -49.21% |
| October 09, 2026 | -48.97% |
| October 08, 2026 | -62.06% |
| October 07, 2026 | -66.84% |
| October 06, 2026 | -66.87% |
| October 05, 2026 | -57.38% |
| October 02, 2026 | -61.92% |
| October 01, 2026 | -53.05% |
| September 30, 2026 | -50.00% |
| September 29, 2026 | -54.33% |
| September 28, 2026 | -49.29% |
| September 25, 2026 | -38.78% |
| September 24, 2026 | -32.23% |
| September 23, 2026 | -34.59% |
| September 22, 2026 | -26.36% |
| September 21, 2026 | -28.52% |
| September 18, 2026 | -27.11% |
| September 17, 2026 | -28.83% |
| September 16, 2026 | -36.53% |
| September 15, 2026 | -13.75% |
| September 14, 2026 | -15.17% |
| September 11, 2026 | -21.03% |
| September 10, 2026 | -27.47% |
| September 09, 2026 | -25.85% |
| September 08, 2026 | -21.77% |
| Date | Value |
|---|---|
| September 04, 2026 | -16.31% |
| September 03, 2026 | -13.79% |
| September 02, 2026 | -2.50% |
| September 01, 2026 | -3.92% |
| August 31, 2026 | -0.98% |
| August 28, 2026 | 13.20% |
| August 27, 2026 | 33.12% |
| August 26, 2026 | 59.38% |
| August 25, 2026 | 67.33% |
| August 24, 2026 | 63.35% |
| August 21, 2026 | 68.70% |
| August 20, 2026 | 60.31% |
| August 19, 2026 | 62.26% |
| August 18, 2026 | 61.20% |
| August 17, 2026 | 60.98% |
| August 14, 2026 | 79.74% |
| August 13, 2026 | 70.18% |
| August 12, 2026 | 58.23% |
| August 11, 2026 | 49.25% |
| August 10, 2026 | 47.57% |
| August 07, 2026 | 50.18% |
| August 06, 2026 | 58.71% |
| August 05, 2026 | 64.31% |
| August 04, 2026 | 67.44% |
| August 03, 2026 | 50.56% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Replimune Group, Inc. | 188.5% |
| Arrowhead Pharmaceuticals, Inc. | 71.51% |
| Oncolytics Biotech, Inc. | -60.56% |
| Sangamo Therapeutics, Inc. | -77.69% |
| Sarepta Therapeutics, Inc. | -21.12% |